CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Home OSE IMMUNOTHERAPEUTICS announces manufacturing agreement with CENEXI
News
2 Sep 2021

OSE IMMUNOTHERAPEUTICS announces manufacturing agreement with CENEXI

OSE IMMUNOTHERAPEUTICS announces manufacturing agreement with CENEXI for clinical batches of covepit, OSE’s multi-target second-generation covid-19 vaccine

Mentioned Companies
PHIXEN
View company profile